Permeability of the blood brain barrier in relation to the development of hepatic encephalopathy was investigated in two animal models of acute hepatic failure, in one of which there was the potential for recovery (D-galactosamine-induced hepatitis). In both this and the hepatic devascularization mo
Blood-Brain barrier permeability to γ-aminobutyric acid in hepatic encephalopathy
✍ Scribed by Mario Baraldi; Gary W. Goldstein
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 209 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Fuller and Hoppel (1) observed hypercarnitinemia in 20 alcoholic cirrhotic patients in contrast to previous reports (2,3) in which normal or low carniine levels were detected.
We measured serum carnitine levels by an enzymaticcolorimetric method (normal, 35 to 70 p M ) (4) in 15 HBsAg-positive nonalcoholic cirrhotics. Free and acyl carnitine levels were normal in five Child A subjects and elevated (101 f 16.5) in 10 Child B-C subjects. Only hypercarnitinemic patients were hyperglucagonemic [470 f 210; volume neutral, 50 to 250 pg per ml (by radioimmunoassay)]. No significant correlation was detected between carnitine levels and height, weight, midupper arm muscle circumference or triceps skin-fold thickness. There was a positive correlation between serum bilirubin levels (r = 0.80, p < 0.001). REFERENCES 1. Fuller RK, Hoppel CL. Elevated plasma carnitine in hepatic cir-
📜 SIMILAR VOLUMES
Sera of patients with hepatic encephalopathy strongly inhibit the specific binding of y-aminobutyric acid to synaptic membranes. In a previous study, this inhibition of specific y-aminobutyric acid binding was attributed to y-aminobutyric acid itself, and it was assumed that serum y-aminobutyric aci
We repeatedly measured blood-brain barrier passage of phenylalanine, leucine, glucose and GABA in nine patients with hepatic encephalopathy using the intravenous double-indicator technique. Controls were four patients without liver disease and two of the patients who had recovered completely from th
The aim of the study was to verify the role of yaminobutyric acid in the pathogenesis of hepatic encephalopathy occurring in cirrhotic patients by attempting to correlate plasma and cerebrospinal fluid content of authentic y-aminobutyric acid with the neurological manifestations of hepatic encephalo
Methotrexate was administered by intraperitoneal injection (100 mg/kg) to unirradiated mice, and to mice receiving varying doses of cranial irradiation. The animals were sacrificed 24 hours after injection, and methotrexate assays were performed on brain tissue. No methotrexate was detected in the